基本信息
浏览量:598
职业迁徙
个人简介
Dr. Fizazi has been involved in many Phase I, II, and III clinical trials as a national or global coordinating investigator. These include GETUG 12 (a 400-patient national Phase III trial testing docetaxel in high-risk localized prostate cancer), GETUG 13 (an international trial in poor-prognosis non-seminomatous germ-cell tumors), and numerous industry-sponsored clinical trials, including the denosumab versus zoledronic acid pivotal study, the TAK700 post-docetaxel and the cabazitaxel-OGX-011 large Phase III trials in castrate-resistant prostate cancer, and the abiraterone Latitude Phase III trial in patients with hormone-naïve metastatic prostate cancer. Dr. Fizazi also coordinated the Peace-1 Phase III trial testing the role of abiraterone acetate and of radiotherapy directed to the prostate in patients with newly diagnosed metastatic prostate cancer treated with ADT, as well as the Peace-2 Phase III trial testing cabazitaxel and pelvic lymph node irradiation in patients with high-risk localized prostate cancer treated with ADT-radiotherapy.
研究兴趣
论文共 621 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 7_Supplement (2024)
Glenn Liu,Xinmeng Jasmine Mu,Karim Fizazi,A. Douglas Laird,Nobuaki Matsubara, Steven M. Yip,Jie Pu,Joan Carles, Andre P. Fay,Robert J. Jones,Stefanie Zschäbitz, Josep M. Piulats,
Cancer Researchno. 7_Supplement (2024)
European urologyno. 3 (2023): 321-330
Journal of Clinical Oncologyno. 6_suppl (2023): LBA17-LBA17
引用13浏览0引用
13
0
Alice Bernard-Tessier, Guillaume Mulier, Paula Nay,Capucine Baldini,Laurence Albiges,Emeline Colomba,Ronan Flippot,Pernelle Lavaud,Natacha Naoun,Anna Patrikidou,Yohann Loriot,Christophe Massard,
引用0浏览0引用
0
0
JOURNAL OF UROLOGY (2023): E129-E130
引用0浏览0引用
0
0
引用3浏览0引用
3
0
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn